This virtual seminar will feature a multidisciplinary panelist of heart failure experts discussing the challenges and opportunities with implementing the updated Guideline-Directed Medical Therapy (GDMT). Attendees will be presented with case study vignettes that will drive meaningful and engaging discussions. Conversations amongst the panelist include how to navigate cost and availability of medication, and how the new value statements may help to support and inform patient engagement.
This program is intended for physicians, nurses, nurse practitioners, pharmacists, and advanced practice professionals that provide care to patients with heart failure.
At the conclusion of this activity, learners will be better able to:
- Explain the updated heart failure guidelines
- Weigh pharmaceutical costs when promoting access to care
- Utilize resources to begin new therapies in a team-based model
All sessions are listed in Eastern Standard Time.
Welcome and Introduction
Topic Discussion: Communication Challenges
Topic Discussion: New Onset of HF
Topic Discussion: SGLT2
Topic Discussion: HfpEF